Bristol Myers Squibb has invested about $100 million into the the injectable drug manufacturing and packaging plant that it ...
Bristol Myers SquibbBMY stock popped Wednesday after the drugmaker delayed the results of a study testing its Cobenfy in patients with Alzheimer's disease psychosis. The delay is due to irregularities ...
Spanish contract drugmaker Laboratorios Farmacéuticos Rovi has officially planted its flag in Phoenix, taking over an ...
The company has informed the National Securities Market Commission (CNMV) that it has completed the Asset Purchase Agreement ...
Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) announced in Q4 CY2025, with sales up 1.4% year on year to $12.5 billion. The company’s full-year revenue guidance of $46.75 billion at the ...
Bristol Myers Squibb has become the latest Big Pharma to tie up a biotech pact as we reach the year’s end, tapping Harbour BioMed for a multiyear research deal. The new pact will see the companies ...
Bristol-Myers Squibb (NYSE: BMY) has considerably lagged behind the overall market, with its stock decreasing by 20% this year, while the S&P 500 index has risen by 14%. This drop can be attributed in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results